chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On Saturday, March 27, I felt a "tingling" in my scalp and in my left eyebrow.  The tingling increased and intensified in the next several days, and by Tuesday evening (March 30), I had a rash down my face from my hairline to just between my eyebrows.  It tingled and felt the tingling changed to a burning/tingling/electric feeling.  By Wednesday morning, the burning had started becoming stronger, when I went to Urgent Care at 7:30 before school to see a doctor.  The physician's assistant at Urgent Care looked at my face and heard my symptoms and diagnosed me with shingles.  She prescribed Tylenol with codeine and Valtrex (Sorry - I don't know the dosage.  I had to take it for 7 days, and I finished it so I threw away the pill bottle).  The Tylenol with codeine did NOTHING for the pain.  It steadily got worse through the week (Wed-Sat) and the rash became blisters.  By Friday afternoon, even though I was on the Valtrex, the shingles had spread and pretty much covered the scalp on the left side of my head and went down my left forehead into my eyelid area.  I saw my ophthalmologist, and he checked my eye and determined it was NOT affecting my ocular nerve and prescribed erythromycin ointment (3.5 gm) to apply to the rash twice daily.  On Saturday, the nerve pain was incredible, and I called Urgent Care to see if there was something else I could try.  When I spoke to a doctor on the phone he prescribed Gabapentin (300 mg, three times daily).  This is what I have been using ever since.  The shingles blisters have gone away and the skin that's left is very red/tender.  I continue to use the erythromycin ointment twice daily and gabapentin.  I still have pain in my left eye and where the shingles are currently subsiding.
Patient reported significant anxiety about the vaccine.  Upon vaccination, administering team noted pallor and the patient reported feeling unwell.  She was provided a glass of water and an ice pack, and rapidly reported feeling better.  VS were obtained and noted at 116/62 HR  76 at time of feeling unwell, and 113/78 after a glass of water.  The patient reported feeling entirely well within approximately 5minutes.  She reported afterward that she had not had breakfast prior to presenting.
arthus type of reaction;redness on lt deltoid area 1 day p/inc progressively, w/lt axilla pain;called in 4-5 days later to report rxn & then given DPH;
Information has been received from a licensed practical nurse concerning a 75 year old white female with no known drug allergies who in 1998 and on 10/12/2004 at 12:10 was vaccinated with a first and second dose of pneumococcal 23v polysaccharide vaccine (lot # 649029/0514P).  Concomitant therapy that day at 12:12 included an eleventh dose of influenza virus vaccine (Fluzone) (lot # U1380AA).  There was no illness at the time of vaccination.  On 10/12/2004 approximately 4 hours later, the patient experienced spreading redness at site and cellulitis at injection site.  The report indicates that the doctor prescribed amoxicillin clavulanate potassium (Augmentin).  Subsequently, the patient recovered from spreading redness at site and cellulitis at injection site.  The report indicates that the patient required medical attention.  No additional information is expected.
Mother noted a red, hot raised area on the child's left upper arm 2 days after receiving the vaccines. It was 3 in in diameter and had a white area in the center. The mother gave the child one dose of Benadryl and the area went away.
Arm swelling and redness from shoulder to elbow. Painful also. Treated with ibuprofen, Benadryl, and ice packs.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 24-Jan-2021, PAIN IN EXTREMITY (sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Ringing ears Full body itching  Tight chest All symptoms are still present at the time of submission
I received the flu shot in left arm and pneumonia shot in right arm. I went home felt bad, arm hurt (right) very bad. Right arm swollen, red, burning. Pain shooting thru arm, chest. That night I feel dizzy, nauseous, pain everywhere, shaking, confused, disoriented. Went to hospital. On the day I took the shots, I had to go to the ER at Medical Center. To this day, I have felt really awful. My body aches all over every day. My left hand hurts so bad I can't pick things up. It has been hard at times to walk and I'm quite disoriented at times. My head and neck hurts, which makes me take EXCEDRIN and Ibuprofen 600 every day. My eyes keep getting red and burning. My ears are ringing constantly and loud. It even hurts to write this letter with my right hand. I can't type well anymore either. I do know it was caused from the pneumonia shot, I have no doubt. I know I am 66 and I have never drank or smoked anything in my life. I was not perfect but now I'm going thru many physical things that last too long.
Severe rash L4-L5 dermatone RT after Zostavax with pain.  05/07/2007 MR received for several OVs from 03/19/2007 through 04/02/2007. Initial visit on 3/19/2007 for c/o Right leg pain which is getting worse. Pain is sharp and stabbing, comes in spasms.  PE shows tendeness to palpation of the Right lower quadriceps along the L4 distribution.  Patellar reflexes 3+/4+ bilaterally. Assessment: Radiculopathy.    F/u visit 3/26/2007 for ? Shingles. PE notes macular papular oozing rash on the Right lower extremity, buttocks, and inner thigh, front of shin. Assessment:  Herpes Zoster.
felt ill, sick; had an increase in the  soreness of the injection site/increasing soreness after injection; extremely fatigued all day; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS, VACCINATION SITE PAIN, and FATIGUE in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037a21b and 044a21a) for COVID-19 vaccination.     Previously administered products included for an unreported indication: OCREVUS on 30-Dec-2020. Concurrent medical conditions included Multiple sclerosis (Patient is on Ocrevus infusion) and Immunosuppression. Concomitant products included OCREVUS from 30-Jun-2021 to an unknown date for Multiple sclerosis, BUPROPION, ADDERALL, FISH OIL, OMEGA 3, and BACLOFEN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS, VACCINATION SITE PAIN, and FATIGUE. The patient was treated with BENADRYL at an unspecified dose and frequency. At the time of the report, ILLNESS, VACCINATION SITE PAIN, and FATIGUE had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement high, Increase in blood pressure.   Patient received 3 doses of the Moderna COVID19 vaccine. Patient stated that he had no side effect following the first two doses.
Pt. received flu shot (AFLURIA, lot # T59607) on 11-12-14 in the late morning and later that evening, broke out in hives over lower body. Denies any new meds. foods, etc. to ER -> rec'd BENADRYL IM, then po rx. Hives subsided.
This spontaneous report was received from a Licensed Practical Nurse and refers to a 1 year old male patient. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications. On 14-JUN-2018, the patient was vaccinated with improperly stored doses of M-M-R II, lot No M045401, expiration date on 14-NOV-2018, subcutaneous in the right thigh, VARIVAX, lot No N031937, Expiration date on 13-NOV-2019, subcutaneously in the left thigh, HAVRIX, Lot No Z4543, intramuscularly in the right thigh and the fourth vaccination with PREVNAR lot No TT86T5, intramuscularly in the left thigh. All the vaccines were administered for prophylaxis. The temperature excursion occurred as a result of a reading from a Digital Data Logger (The timeframes and temperatures were not reported). This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1807USA006096: US-009507513-1807USA010900.
Developed redness, pain at injection site.  Erythema start: 12/2003, edema at injection site 50-120mm start: 12/2003, pain start: 12/2003.
Left arm weakness/paralysis onset 2 hrs following flu vaccine. Seen at hosp ER on 10-9-14 D/T persistent paralysis. Nov 12, 2014 Diagnosed with Guillain Barre Syndrome by neurologist. Partial recovery of strength since that time.
19:00 (11 hrs post vaccination) - headache, fatigue 22:00 - headache, fatigue and muscle aches 02:00 - worsening headache, despite Motrin, chills 03:00 - dizziness, fatigue, aching all over, weakness, tightening in chest, having to put more effort into breathing. 99.9 fever, palpitations, heart rate 100-130
I noticed that I was getting a rash, I thought it was getting better and eventually got worse. So almost two weeks after the injection I went a sought medical attention. It didn't really hurt, it was just huge red and a little bit swollen. My DR had seen one case like this prior to my visit, she had me take two benadryl a day for the next 6 days and then it was gone.
pt shaking & jerking all over reports parent; 29JUN95 ER report found by GM this AM shaking all over, lasting 1min then started crying; T100.2 R; MD dx likely viral fever; sz, febrile; happy baby @ ER;
Extremely itchy rash on back, under breasts....   started about 2 days after the 1st injection.    Skin is bumpy, not red on back, but under breasts are red spots with redness in the crease.
Admitted to hospital on 10/22/03 for fever with abnormal movements. Work up was unremarkable. NL CT, EEG, MRI. The medical records state hand jerking and facial twitching.
Pt had swelling in arm that occurred 3 days later; she went to family Dr due to redness, swelling, fever. Area was as large as grapefruit. Dr told her it was not a reaction to vaccine, it was bacterial infection. Placed on KEFLEX 500mg.
On 1/7/21,  at approx 1:05 PM, Maria noticed she was feeling very sleepy.  Her co-workers noticed her left arm had bluish color, cold temp, and she had some tingling in her arm.  Her blood pressure was elevated at 160/100.  Patient was evaluated by Dr. and she recommended patient follow up in the ED.  Patient was taken to ED by her Director.  She states that ED staff told her this was a common reaction and that they would observe her for a couple hours.  Her blood pressure decreased to less than 140/90.  She states she was feeling better and returned to work  at 4:40 PM to finish her shift.
sudden bilat hearing loss 9sensory neuro) dec to 55 dec;swelling of proximal rt index finger also noted could be r/t flu vax;
Initial unsolicited report received from other non-healthcare professional on 24-Jan-2017. This case involves a female patient (age was reported as 25 or 26-year-old) was vaccinated with a dose of Fluzone QIV (batch number: UI669AD, expiry date: 30-Jun-2017, dose, dose in series, route and site of administration was not reported) on 29-Sep-2016. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, a medical condition was reported as unknown. Concomitant medication was not reported. On an unknown day, following the vaccination, patient experienced numbness of left side and paralysis. The patient required emergency visit. It was also reported that the patient was hospitalized several different times from 29-Sep-2016 to 24-Jan-2017. Lab data and corrective treatment were not reported. Outcome of events reported as not recovered. List of documents held by sender: none. Sender's Comments: Experienced numbness of left side and paralysis are unlisted with FLUZONE QIV. This is very poorly documented case. However patient's immune status, medical history, concomitant medication etc. is require to further assess this case.
Information has been received from a physician assistant referring to a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapy were not reported. On an unspecified date in 2014, the patient started GARDASIL (strength, dose, frequency, route, lot# and expiration date were unknown) for prophylaxis. On 17-JUL-2018, the patient received GARDASIL 9 (strength, dose, frequency, route, lot# and expiration date were unknown) for prophylaxis. No adverse effects were reported. No product quality compliant (PQC) involved.
HIves at injection site; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE URTICARIA (HIves at injection site) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE URTICARIA (HIves at injection site) and HEADACHE (Headache). At the time of the report, INJECTION SITE URTICARIA (HIves at injection site) and HEADACHE (Headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The age range of the patient was provided as 28-35 years.  No treatment information was provided.  No concomitant medications was provided.
Approximately 11:30 pm same days as vaccination (8 hours post shot), I lost the ability to detect hot liquids in my mouth.  Normally rinse mouth with warm water after brushing teeth.  When I rinsed mouth, water was cool.  Put very hot water in cup,; too hot to immerse finger, but water still felt cool in my mouth.  The next day, symptom had subsided, but it took 2 days for temp sensation in mouth to return to normal.
sick stomach, face puffed up;stiffening arms & legs, chest & back pains, impaired speech, vision;legs numb got worse & worse;constant urination;
DOSE ADMINSISTERED  ON 4.4.2021 AFTER THE VIAL HAD BEEN PUNCTURED ON 3.25.2021
Per employee, upon arising at 5:30am, this morning she noticed mild swelling with redness of left upper arm and at 12:00 noon she noticed 2 small lymph nodes on left lateral side of neck only. No tx.
Redness, swelling, weakness and pain 24 hours after. T 98.4. No adenopathy? cellulitis. RX with Rocephin 1gm and start Keflex. Discolorization of arm which is resolving. Advised Td in future - No Tdap. per ID doctor.
Patient developed rash with red bumps and redness in the eyes.  Relieved by taking diphenhydramine.
Myalgia, right deltoid pain, possible fever (patient never confirmed this). Symptoms improving as of 4/24/13.
This spontaneous report was received from a nurse regarding a patient of unknown age and gender. There was no information pertinent medical history and drug reactions and allergies. On 12-AUG-2014, the patient was inadvertently vaccinated with MMR II (dose, units not reported) Product lot # H014650, subcutaneously which expired on 03-AUG-2014. No adverse effects reported. There was no product quality complaint involved. The outcome of the event was unknown. Additional information has been requested.
Dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "recovering", described as "Dizzy".  Additional Information: Reporter stated that the patient felt dizzy too but was better now.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient had sweating, dizziness, light headache. Vital signs stable. Feeling well after 30 minutes, stable, released from vaccination site.
Cumulative thimerosol, resulting in mercury induced developmental delay. Chelation therapy DMSA 100mg X 3. The annual follow-up states that the pt is still exhibiting autistic like behaviors and is nerologically damaged. He is still non-verbal and still is developmentally delayed.
Swelling in the face; This is a spontaneous report from a non-contactable other health professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265), via an unspecified route of administration on 27Jan2021 (at the age of 52years) at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swelling in the face on 28Jan2021. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was recovering. This case is non-serious.  No follow-up attempts are possible. No further information is expected.
77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.; 77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.) and NO ADVERSE EVENT (No adverse event). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.), POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for PRODUCT TEMPERATURE EXCURSION ISSUE (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.) and POOR QUALITY PRODUCT ADMINISTERED (77 patients received Moderna bivalent booster doses that had undergone a temperature excursion.).    This case was for 76 patient out of 77 patients reported.  No concomitant medication information provided.  It was reported that 77 patients received Moderna bivalent booster doses that had undergone a temperature excursion. The doses were administered before it was known if the vaccine was ok to use after the excursion.  No treatment information provided.   This case was linked to MODERNATX, INC.-MOD-2023-696122 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2023-696122: Master case
I have Bell's palsy after receiving my second dose of Pfizer; This is a spontaneous report from a non-contactable consumer (patient). A 23-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 23-years-old) as dose 2, single for covid-19 immunization. The patient medical history included covid-19. Concomitant medications were not reported. The patient historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: solution for injection, lot number was not reported), via an unspecified route of administration on an unspecified date (at the age of 23-years-old) as dose 1, single for covid-19 Immunisation. Patient was not pregnant at time of Vaccination (Prior to vaccination, the patient was diagnosed with COVID-19). Since the vaccination, the patient has not been tested for COVID-19. It was reported that, the patient had bell's palsy after receiving her second dose of Pfizer. The adverse event resulted in emergency room/department or urgent care and hospitalization. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
-large area of redness, swelling itchiness on patient's upper arm, with line of demarcation, hot to the touch. -MD prescribed cefpodoxime 100 mg BIDx7 days on 12/13 (2 days post vaccination)
Information has been received from a Healthcare worker concerning a 24 year old female patient. The patient's medical history, concurrent condition and concomitant therapy were not provided. On 07-APR-2015, the patient was vaccinated with GARDASIL (lot#, expiration date, route and dose not reported). The patient jumped when the needle was inserted into her arm (the patient was scared to needles), and she did not receive the full dose of the vaccine. A full dose of GARDASIL was re-administered at the same office on 07-APR-2015. No adverse effects were reported. Additional information has been requested.
A report was received from a health professional on 23Oct02, concerning a 39 year old female health professional who was inadvertently administered Fluvirin vaccine in Oct 2002. The health professional did not experience any adverse event. The event resolved. There was insufficient information to determine the reporters causality assessment. Cross-reference with PJP 2002 00638. Update 1 09Dec02: The vaccinee received the Fluvirin vaccine on 23Oct02.
Information has been received from a mother concerning her daughter who was vaccinated with Gardasil vaccine. After receiving the second dose of Gardasil the patient's mother reported that her daughter experience injection site pain. The patient's outcome was not reported. Additional information has been requested.
I had migratory polyarthralgia which has only significantly diminished more than one year later, I also had abdominal pain, bloating, and extreme fatigue and dyspnea on exertion.